MedicalMulti-arm surgery robot

SSi Mantra

Name: SSi Mantra
Brand: SS Innovations

SSi Mantra is a surgical robot from India with several arms, a 3D view and an open surgeon console. It is used for many kinds of operations, including heart surgery, and has been used for long-distance remote surgery. MassDevice, 8 Dec 2025

Stage 4 of 5

Paying customers

Which rule placed it

Evidence: Company-reported only
Human help: None reported
Last milestone: 14 Aug 2026

01Can I get it?

Yes, in places

Where it works today: 224 systems in 12 countries as of mid-2026, mostly outside the US; not yet FDA-cleared. MassDevice, 14 Aug 2026
Published price: No published price in our sources.
Human help: A surgeon steers the robot from a console, sometimes from far away, with surgeons at the bedside.

02Track record

What has actually happened

Every milestone is dated and links to the page it comes from. Lines marked company-reported rest on the maker's own word.

14 Aug 2026
Paying customers · sets the stage
SS Innovations installed 30 new robots in April to June 2026, bringing the total to 224 in 12 countries and more than 12,200 surgeries.
MassDevice, 14 Aug 2026Company-reported
4 June 2026
Demo
The company's CEO, in Georgetown, Guyana, did part of a heart operation on a patient in Indore, India, about 12,500 miles away, with surgeons at the patient's bedside.
MassDevice, 4 June 2026Company-reported
9 March 2026
Funding
SS Innovations raised $18.6 million by selling shares privately, to prepare for the US and EU markets.
MassDevice, 9 Mar 2026Company-reported
8 Dec 2025
Update
SS Innovations sent SSi Mantra to the FDA for review under the 510(k) route, covering general, urology, bowel, gynecology and heart surgery. It is not yet cleared.
MassDevice, 8 Dec 2025Company-reported
8 May 2025
Paying customers · sets the stage
The company said more than 3,800 surgeries had been done with SSi Mantra, including over 200 heart operations.
MassDevice, 8 May 2025Company-reported
10 April 2024
Demo
Surgeons used SSi Mantra for remote operations on an animal 5 km away, the company's first telesurgery.
MassDevice, 10 Apr 2024Company-reported
9 Aug 2023
Paying customers · sets the stage
SS Innovations, which already had approval from Indian regulators, filled its first order outside India: a robot for Aster Hospital in Dubai.
MassDevice, 9 Aug 2023Company-reported

03Promised vs delivered

What the maker said, and when

Dated targets the maker set in public, against what has happened since.

Said11 Sept 2024
FDA clearance by end of 2025
SS Innovations said it expected to get US regulatory sign-off for SSi Mantra by the end of 2025. MassDevice, 11 Sept 2024
Missed
It only sent its 510(k) to the FDA in December 2025, and the review was still pending in August 2026.
Said8 May 2025
FDA submission in July 2025
SS Innovations said it would send SSi Mantra 3 to the FDA in July 2025. MassDevice, 8 May 2025
Missed
The 510(k) was submitted in December 2025.

04Safety and incidents

What has gone wrong

No crashes, recalls or regulator reports in our sources. That is not proof none happened; we add them when a regulator or trusted outlet reports one.

How we placed it

The rule, not an opinion

Stages are worked out by published rules from the dated milestones above. We never rate robots, and no maker can pay to change a stage.

5
Regulator-cleared or mass market
A regulator has cleared it where approval applies: FDA clearance or approval for a medical robot, a permit to run with no one aboard for a self-driving vehicle, or an FAA approval for routine drone flights. Or: Widely sold: sales in the hundreds of thousands, or a product category you can buy in ordinary shops.
4
Paying customersThis robot
Delivered to customers who pay for it, beyond a trial, or a paid service the public can use.
Placed by: SS Innovations installed 30 new robots in April to June 2026, bringing the total to 224 in 12 countries and more than 12,200 surgeries (14 Aug 2026); The company said more than 3,800 surgeries had been done with SSi Mantra, including over 200 heart operations (8 May 2025).
3
Pilot
Working with a named customer in a real setting, as a trial.
2
Pre-orders
Orders, reservations or deposits taken, with nothing delivered yet.
1
Demo only
Shown in videos, staged events or a factory, with no units working for customers.

What we couldn't confirm. The company is listed on Nasdaq with an address in Fort Lauderdale, Florida, but its headquarters and robot work are in Gurugram, India; country set to IN. The date of its first Indian approval was not found. FDA review was still pending as of August 2026.

Sources

Cite this page

Robotics Verdict. “SSi Mantra (SS Innovations): how far has it got?” roboticsverdict.com/robots/ssi-mantra. Checked 19 October 2026.